InnoCare Pharma HK$2.24 billion IPO
Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Tianfeng Securities $100 million notes offering
Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…
Zensun Group $200 million senior high-yield notes offering
Davis Polk advised the initial purchasers in connection with a debut Regulation S offering by Zensun Enterprises Limited of $200 million 12.5% senior notes due 2022. The notes are…
Xi’an Aerospace High-Tech Industry Development $100 million bond offering
Davis Polk advised the joint lead managers on a Regulation S offering by Xi’an Aerospace High-Tech Industry Development Co., Ltd, a company incorporated in the People’s Republic of China…
China South City Holdings $225 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a $225 million Regulation S only offering by China South City Holdings Limited of its 10.875% senior notes due 2022.
CSC is a…
Fujian Yango $110 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $110 million principal amount of 12.5% senior notes due 2022 by Yango (Cayman) Investment Limited…
Hong Kong Television Network HK$464 million top-up placing of shares
Davis Polk advised the sole placing agent for the placement of an aggregate of 90,000,000 ordinary shares in Hong Kong Television Network Limited for a total consideration of approximately…
CITIC Capital Acquisition $276 million IPO
Davis Polk advised the sole underwriter in connection with the initial public offering of 27,600,000 units of CITIC Capital Acquisition Corp., including 3,600,000 units purchased pursuant…
Innovent Biologics HK$2.4 billion placing of shares
Davis Polk advised the sole placing agent for the primary placement of an aggregate of 78,000,000 new shares in Innovent Biologics, Inc. for a total consideration of approximately HK$2.4…
RiseSun Real Estate Development $300 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with the Regulation S offering of $300 million principal amount of 8.750% senior notes due 2021 by RongXingDa Development (BVI)…